Home > Healthcare > Pharmaceuticals > Finished Drug Form > Cancer Biological Therapy Market
Cancer Biological Therapy Market Share
- Report ID: GMI676
- Published Date: Jan 2023
- Report Format: PDF
Cancer Biological Therapy Market Share
Some leading companies in the cancer biological therapy market include
- AbbVie Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- Bayer AG
- Bristol-Myers Squibb Company
- Eisai Co., Ltd.
- Merck
- AstraZeneca
- GlaxoSmithKline plc
- ELI Lilly and Company
- Incyte
- Otsuka
- Pfizer
- Sanofi
- F. Hoffmann-La Roche
- Novartis
- Takeda Pharmaceuticals
- Seattle Genetics
- Spectrum Pharmaceuticals
These companies are focusing on product innovations to achieve competitive lead.
Frequently Asked Questions (FAQ) :
Global market for cancer biological therapy was worth more than USD 111.5 billion in 2022 and is projected to record over 7% CAGR from 2023-2032.
Blood cell growth factors (BCGF) is estimated to surpass USD 50 billion by 2032 due to increasing use in preventing side effects of cancer treatments.
Europe cancer biological therapy market size is slated to reach over USD 55.5 billion by 2032 led by rising cases of cancer and the surging geriatric population.
AbbVie Inc., Amgen Inc., Bayer AG, Merck, AstraZeneca, Incyte, Otsuka, Pfizer, Sanofi, Novartis, Seattle Genetics are some of the key manufacturers of cancer biological therapy worldwide.
Cancer Biological Therapy Market Scope
×
Get a free sample of
Cancer Biological Therapy Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below